MBody AI Ltd(MBAI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:00 PM ET (Korea 9/12 05:00)
Full metrics table
| Index | - | P/E | 1.24 | EPS (ttm) | 5.17 | Insider Own | 15.54% | Shs Outstand | 1.4M | Perf Week | -1.54% |
| Market Cap | 0.09B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.1M | Perf Month | -28.01% |
| Enterprise Value | 0.09B | PEG | - | EPS next Q | - | Inst Own | 0.84% | Short Float | 2.27% | Perf Quarter | -33.26% |
| Income | 0.00B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 1.46 | Perf Half Y | -44.59% |
| Sales | 0.00B | P/B | 1.87 | EPS next 5Y | - | ROA | - | Short Interest | 0.03M | Perf YTD | -43.56% |
| Book/sh | 3.43 | P/C | 399.47 | EPS past 3/5Y | - | ROE | - | 52W High | -76.68% ($27.44) | Perf Year | 33.28% |
| Cash/sh | 0.02 | P/FCF | - | Sales past 3/5Y | - | ROIC | 120.45% | 52W Low | 36.44% ($4.69) | Perf 3Y | -74.35% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 6.23% 7.43% | Perf 5Y | -95.56% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.57 | Perf 10Y | -99.82% |
| Dividend Ex-Date | - | Quick Ratio | 0.05 | EPS Q/Q | 1.58% | Profit Margin | - | RSI (14) | 35.13 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.05 | Sales Q/Q | - | SMA20 | -11.08% ($7.2) | Beta | 0.74 | Target Price | $50 |
| Payout | - | Debt/Eq | 0.01 | Earnings | - | SMA50 | -16.66% ($7.68) | Rel Volume | 1.76 | Prev Close | $6.6 |
| Employees | - | LT Debt/Eq | 0 | EPS/Sales Surpr. | 46.99% - | SMA200 | -39.82% ($10.63) | Avg Volume(3M) | 0.02M | Price | $6.4 |
| IPO | 2015/3/18 | Option/Short | No/Yes | Trades | 820 | Volume | 31,409 | Change | -3.03% |
Company
MBAI is a Technology sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🤖 An ultra-small Embodied AI company that integrates the control of robots, sensors, and autonomous mobile units into a single "AI Orchestrator" layer to automate tasks in hospitality, logistics, healthcare, and office settings. This Nasdaq-listed company was reborn in December 2025 through a reverse merger with Check-Cap, an Israeli medical device company that was originally developing a colorectal cancer screening capsule.
Over the past 1 year, on the lower side
77% below its 1-year high.
MBAI has weak earning power
Tap to view numbers
The stock looks undervalued
Trading at 1.2 times earnings.
Tap to view numbers
Opinions on the outlook are split
Positive and negative signals are mixed
Tap to view numbers
Holding long would have lost money
Would have changed by -74.3% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 0.8%.
Tap to view numbers
It ranks #4 in the industry
Based on market cap of $88M.
MBAI $88M PER 1.2
MSFT $3.7T PER 27.6
ORCL $433B PER 23.6
PLTR $402B PER 142.5
FAQ
What kind of company is MBAI?
MBAI belongs to the Technology sector and operates in the Software - Infrastructure industry.
What is the market cap of MBAI?
The market cap of MBAI is approximately $88M, ranking 4,641 within its sector.
What is the P/E ratio of MBAI?
MBAI has a P/E ratio of approximately 1.2x, which can be used to assess its valuation relative to the Technology sector average.
What is the 52-week high and low for MBAI?
MBAI has recorded a 52-week high of $27.44 and a low of $4.69.
